packageLoncastuximabTesirine

loncastuximab tesirine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Loncastuximab tesirine is an antibody-drug conjugate used to treat diffuse large B-cell lymphoma. It is an approved medicine, with one product authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q39057117 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:loncastuximab tesirine
ATC codes:L01FX22
DrugBank:DB16222
Wikidata:Q39057117
molar mass:151000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown